Use of disease-modifying drugs during pregnancy and breastfeeding
dc.contributor.author | Dobson, R | |
dc.date.accessioned | 2021-04-01T10:42:27Z | |
dc.date.available | 2021-02-19 | |
dc.date.available | 2021-04-01T10:42:27Z | |
dc.identifier.issn | 1080-8248 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/71028 | |
dc.publisher | Lippincott, Williams & Wilkins | en_US |
dc.relation.ispartof | Current Opinion in Neurology | |
dc.title | Use of disease-modifying drugs during pregnancy and breastfeeding | en_US |
dc.type | Article | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Accepted | en_US |
dcterms.dateAccepted | 2021-02-19 |
Files in this item
This item appears in the following Collection(s)
-
Centre for Cancer Prevention [1181]